Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome

Clinical and Experimental Medicine

Volumn 10, Issue 1, 2010, Pages 33-40

  Bhushan, Bharat ^a   Chauhan, Pradeep Singh ^a   Saluja, Sumita ^a   Verma, Saurabh ^a   Mishra, Ashwani Kumar ^a   Siddiqui, Saeed ^b   Kapur, Sujala ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Aberrant phenotype; Acute leukemia; Clinical outcome; Flow cytometry; Prognosis factors

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CHILDHOOD LEUKEMIA; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; T CELL LEUKEMIA;

ADOLESCENT; ADULT; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID, ACUTE; MALE; PHENOTYPE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 75049086053     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-009-0067-8     Document Type: Article

References (45)

1. CL Reading EH Estey YO Huh, et al. 1993 Expression of unusual immunophenotype combinations in acute myelogenous leukemia Blood 81 11 3083 3090 1:STN:280:DyaK3s3ntFCqtA%3D%3D 8499643
2. A Macedo A Orfao MB Vidriales, et al. 1995 Characterization of aberrant phenotypes in acute myeloblastic leukemia Ann Hematol 70 4 189 194 10.1007/BF01700374 1:STN:280:DyaK2M3mslykug%3D%3D 7748963
3. HS Khalidi LJ Medeiros KL Chang RK Brynes ML Slovak DA Arber 1998 The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification and karyotypic abnormalities Am J Clin Pathol 109 2 211 220 1:STN:280:DyaK1c3ktlamsA%3D%3D 9583894
4. DM Bahia M Yamamoto L Chauffaille Mde, et al. 2001 Aberrant phenotypes in acute myeloid leukemia: a high frequency and its clinical significance Haematologica 86 8 801 806 1:STN:280:DC%2BD3MvnvFWjtg%3D%3D 11522535
5. O Legrand JY Perrot M Baudard, et al. 2000 The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score Blood 96 3 870 877 1:CAS:528:DC%2BD3cXltlKit7s%3D 10910899
6. JM Cruse RE Lewis S Pierce J Lam Y Tadros 2005 Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias Exp Mol Pathol 79 1 39 41 10.1016/j.yexmp.2005.02.003 1:CAS:528:DC%2BD2MXlvFKqs7Y%3D 16005710 (Pubitemid 40984750)
7. AH El-Sissy MA El-Mashari WY Bassuni AF El-Swaayed 2006 Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia J Egypt Natl Cancer Inst 18 3 244 249
8. HG Drexler E Thiel WD Ludwig 1991 Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia Leukemia 5 8 637 645 1:STN:280:DyaK3MzlvFOitA%3D%3D 1886419
9. DH Boldt KJ Kopecky D Head G Gehly JP Radich FR Appelbaum 1994 Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience Leukemia 8 12 2118 2126 1:STN:280:DyaK2M7gs1yjsg%3D%3D 7807999
10. HA Preti YO Huh SM O'Brien, et al. 1995 Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis Cancer 76 9 1564 1570 10.1002/1097-0142(19951101)76:9<1564:: AID-CNCR2820760911>3.0.CO;2-1 1:STN:280:DyaK283itlaitw%3D%3D 8635059
11. HQ Shen YM Tang SL Yang, et al. 2003 Immunophenotyping of 222 children with acute leukemia by multi-color flow cytometry Zhonghua Er Ke Za Zhi 41 5 334 337 14751050
12. A Vitale A Guarini C Ariola, et al. 2007 Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial Haematologica 92 3 342 348 10.3324/haematol.10385 1:CAS:528:DC%2BD2sXhtFGqu77K 17339183 (Pubitemid 350143543)
13. HG Drexler E Thiel WD Ludwig 1993 Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance Leukemia 7 4 489 498 1:STN:280:DyaK3s3hvValsQ%3D%3D 7681917
14. H Firat R Favier M Adam, et al. 2001 Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones Leuk Lymphoma 42 1-2 75 82 1:CAS:528:DC%2BD3MXmtVOgsr0%3D 11699224 (Pubitemid 32700924)
15. LJ Smith JE Curtis HA Messner JS Senn H Furthmayr EA McCulloch 1983 Lineage infidelity in acute leukemia Blood 61 6 1138 1145 1:STN:280: DyaL3s7nvFaksw%3D%3D 6404327
16. AH Cross RM Goorha R Nuss, et al. 1988 Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity Blood 72 2 579 587 1:STN:280:DyaL1c3psVeisA%3D%3D 3261183
17. ED Ball RB Davis JD Griffin, et al. 1991 Prognostic value of lymphocyte surface markers in acute myeloid leukemia Blood 77 10 2242 2250 1:STN:280:DyaK3M3jtVemsg%3D%3D 1709379
18. FO Smith BC Lampkin C Versteeg, et al. 1992 Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance Blood 79 9 2415 2422 1:STN:280: DyaK383jvFyquw%3D%3D 1571553
19. SJ Kuerbitz CI Civin JP Krischer, et al. 1992 Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study J Clin Oncol 10 9 1419 1429 1:STN:280:DyaK38zovV2lsw%3D%3D 1517785
20. RE Sobol R Mick I Royston, et al. 1987 Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia N Engl J Med 316 18 1111 1117 1:STN:280:DyaL2s3gtFOjtg%3D%3D 3494942
21. SR Wiersma J Ortega E Sobel KI Weinberg 1991 Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood N Engl J Med 324 12 800 808 1:STN:280:DyaK3M7kvVKksA%3D%3D 1997852
22. A Reiter M Schrappe WD Ludwig, et al. 1992 Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group Blood 80 10 2471 2478 1:STN:280:DyaK3s%2FktlaqsA%3D%3D 1421370
23. CH Pui FG Behm WM Crist 1993 Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia Blood 82 2 343 362 1:STN:280:DyaK3szitVCisw%3D%3D 8329694
24. FM Uckun HN Sather PS Gaynon, et al. 1997 Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group Blood 90 1 28 35 1:CAS:528: DyaK2sXktlaqsbo%3D 9207434
25. B Bhushan D Ahuja S Verma S Saluja S Siddiqui S Kapur 2007 Relation of cell viability and apoptosis with clinical remission following induction chemotherapy in ALL and AML J Exp Clin Cancer Res 26 3 313 321 1:CAS:528:DC%2BD2sXhtlSlur7M 17987789
26. S Kawai Z Zha Y Yamamoto H Shimizu T Fujimoto 1995 Clinical significance of childhood acute myeloid leukemias expressing lymphoid-associated antigens Pediatr Hematol Oncol 12 5 463 469 10.3109/08880019509009476 1:CAS:528:DyaK2MXptFOitb8%3D 8519631
27. H Zhu T Niu W Meng C Xu S Lei 2002 Immunophenotype of acute leukemia and its clinical significance Hua Xi Yi Ke Da Xue Xue Bao 33 1 118 120 1:CAS:528:DC%2BD38XhsFKisrg%3D 12599447
28. F Lo Coco G De Rossi D Pasqualetti, et al. 1989 CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity Br J Haematol 73 4 480 485 10.1111/j.1365-2141.1989.tb00284.x 1:STN:280:DyaK3c7it1Kgug%3D%3D 2482063
29. MM Zutter PJ Martin D Hanke PG Kidd 1990 CD7+ acute non-lymphocytic leukemia: evidence for an early multipotential progenitor Leuk Res 14 1 23 26 10.1016/0145-2126(90)90142-V 1:STN:280:DyaK3c7lslCrsg%3D%3D 1689436 (Pubitemid 20061899)
30. AW Jensen M Hokland H Jorgensen J Justesen J Ellegaard P Hokland 1991 Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: identification of a group of patients with similar T-cell receptor beta and delta rearrangements and course of disease suggestive of poor prognosis Blood 78 5 1292 1300 1:STN:280:DyaK3Mzks1ynsw%3D%3D 1715222
31. K Kita H Miwa K Nakase, et al. 1993 Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma Blood 81 9 2399 2405 1:STN:280:DyaK3s3ksVCgtw%3D%3D 7683218
32. G Del Poeta R Stasi A Venditti, et al. 1994 Prognostic value of cell marker analysis in de novo acute myeloid leukemia Leukemia 8 3 388 394 1:STN:280:DyaK2c7ntlSrtQ%3D%3D 7907393 (Pubitemid 24096691)
33. A Saxena DP Sheridan RT Card AM McPeek CC Mewdell LF Skinnider 1998 Biologic and clinical significance of CD7 expression in acute myeloid leukemia Am J Hematol 58 4 278 284 10.1002/(SICI)1096-8652(199808)58:4<278::AID- AJH5>3.0.CO;2-N 1:STN:280:DyaK1czlsFWiug%3D%3D 9692390 (Pubitemid 28346013)
34. RE Lewis JM Cruse CM Sanders RN Webb JL Suggs 2007 Aberrant expression of T-cell markers in acute myeloid leukemia Exp Mol Pathol 83 3 462 463 10.1016/j.yexmp.2007.08.010 1:CAS:528:DC%2BD2sXhtlagsbzE 17927977 (Pubitemid 350087031)
35. K Kita K Nakase H Miwa, et al. 1992 Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34 Blood 80 2 470 477 1:STN:280:DyaK38zivF2nsA%3D%3D 1378322
36. R Thalhammer-Scherrer G Mitterbauer I Simonitsch, et al. 2002 The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination Am J Clin Pathol 117 3 380 389 10.1309/C38D-D8J3-JU3E-V6EE 11888077 (Pubitemid 34226072)
37. JL Suggs JM Cruse RE Lewis 2007 Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias Exp Mol Pathol 83 3 471 473 10.1016/j.yexmp.2007.08.012 1:CAS:528:DC%2BD2sXhtlagsb3M 17963747 (Pubitemid 350087033)
38. SM Ng WA Ariffin HP Lin LL Chan YM Chin 2000 Clinical features and treatment outcome of children with myeloid antigen coexpression in B-lineage acute lymphoblastic leukemia: a study of 151 Malaysian children J Trop Pediatr 46 2 73 78 10.1093/tropej/46.2.73 1:STN:280:DC%2BD3c3ot1ensg%3D%3D 10822932
39. CH Pui SC Raimondi DR Head, et al. 1991 Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse Blood 78 5 1327 1337 1:STN:280:DyaK3Mzks1yntw%3D%3D 1878594
40. J Zheng X Wang Y Hu, et al. 2008 A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China Cytometry B Clin Cytom 74 1 25 29 18061959
41. MN Yenerel T Atamer AS Yavuz, et al. 2002 Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study Ann Hematol 81 9 498 503 10.1007/s00277-002-0524-x 1:CAS:528:DC%2BD38Xns1entrY%3D 12373349 (Pubitemid 36075501)
42. U Creutzig J Harbott C Sperling, et al. 1995 Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87 Blood 86 8 3097 3108 1:CAS:528:DyaK2MXos1ynsLc%3D 7579404
43. MJ Borowitz JJ Shuster CI Civin, et al. 1990 Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study J Clin Oncol 8 8 1389 1398 1:STN:280:DyaK3czjvFWjsg%3D%3D 1696310
44. CH Pui ML Hancock DR Head, et al. 1993 Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia Blood 82 3 889 894 1:STN:280:DyaK3szjtlSqug%3D%3D 7687897
45. N Cascavilla P Musto G D'Arena S Ladogana R Matera M Carotenuto 1997 Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression Haematologica 82 1 31 37 1:STN:280: DyaK2s3mtFSntw%3D%3D 9107079